Cardiff Oncology's market cap is currently $137.04M. The company's EPS TTM is $-0.21; its P/E ratio is ―; Cardiff Oncology is scheduled to report earnings on July 29, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
